Literature DB >> 10366514

Induction of beta-sheet structure in amyloidogenic peptides by neutralization of aspartate: a model for amyloid nucleation.

J Orpiszewski1, M D Benson.   

Abstract

Amyloid fibril formation is widely accepted as a critical step in all types of amyloidosis. Amyloid fibrils derived from different amyloidogenic proteins share structural elements including beta-sheet secondary structure and similar tertiary structure. While some amyloidogenic proteins are rich in beta-sheet in their soluble form, others, like Alzheimer beta-amyloid peptide (Abeta) or serum amyloid A, must undergo significant structural transition to acquire a high beta-sheet content. We postulate that Abeta and other amyloidogenic proteins undergo a transition to beta-sheet as a result of aging-related chemical modifications of aspartyl residues to the form of succinimide or isoaspartyl methyl ester. We hypothesize that spontaneous cyclization of aspartate residues in amyloidogenic proteins can serve as a nucleation event in amyloidogenesis. To test this hypothesis, we synthesized a series of designed peptides having the sequence VTVKVXAVKVTV, where X represents aspartic acid or its derivatives. Studies using circular dichroism showed that neutralization of the aspartate residue through the formation of a methyl ester or an amide, or replacement of aspartate with glutamate led to an increased beta-sheet content at neutral and basic pH. A higher content of beta-sheet structure correlated with increased propensity for fibril formation and decreased solubility at neutral pH. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10366514     DOI: 10.1006/jmbi.1999.2768

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

1.  A cavity-forming mutation in insulin induces segmental unfolding of a surrounding alpha-helix.

Authors:  Bin Xu; Qing-Xin Hua; Satoe H Nakagawa; Wenhua Jia; Ying-Chi Chu; Panayotis G Katsoyannis; Michael A Weiss
Journal:  Protein Sci       Date:  2002-01       Impact factor: 6.725

2.  Mutations in the B1 domain of protein G that delay the onset of amyloid fibril formation in vitro.

Authors:  Marina Ramírez-Alvarado; Melanie J Cocco; Lynne Regan
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

3.  The 3D profile method for identifying fibril-forming segments of proteins.

Authors:  Michael J Thompson; Stuart A Sievers; John Karanicolas; Magdalena I Ivanova; David Baker; David Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-07       Impact factor: 11.205

4.  A pH-dependent conformational transition of Abeta peptide and physicochemical properties of the conformers in the glial cell.

Authors:  Yoichi Matsunaga; Nobuhiro Saito; Akihiro Fujii; Junichi Yokotani; Tadakazu Takakura; Tomoaki Nishimura; Hiroyuki Esaki; Tatsuo Yamada
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

Review 5.  APP/Aβ structural diversity and Alzheimer's disease pathogenesis.

Authors:  Alex E Roher; Tyler A Kokjohn; Steven G Clarke; Michael R Sierks; Chera L Maarouf; Geidy E Serrano; Marwan S Sabbagh; Thomas G Beach
Journal:  Neurochem Int       Date:  2017-08-12       Impact factor: 3.921

6.  The impact of extra-domain structures and post-translational modifications in the folding/misfolding behaviour of the third PDZ domain of MAGUK neuronal protein PSD-95.

Authors:  Javier Murciano-Calles; Marta Marin-Argany; Eva S Cobos; Sandra Villegas; Jose C Martinez
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

7.  Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.

Authors:  Qi Wang; Joshua L Johnson; Nathalie Y R Agar; Jeffrey N Agar
Journal:  PLoS Biol       Date:  2008-07-29       Impact factor: 8.029

8.  Post-translational modifications modulate ligand recognition by the third PDZ domain of the MAGUK protein PSD-95.

Authors:  Javier Murciano-Calles; Carles Corbi-Verge; Adela M Candel; Irene Luque; Jose C Martinez
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.